GlassScriptPhysician profile
Tara A Shipman
NPI 1992700751
$5,673.84
in general payments reported to CMS, 2019-2025
27 companies · $842 in 2025
The $842 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $178 · 2021: $609 · 2022: $1,292 · 2023: $1,223 · 2024: $1,168 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,900 · Education: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,900.14 |
| Education | $332.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $980.60 | 2021-2025 | |
| Astellas Pharma US INC | $705.28 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $701.98 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $492.63 | 2023-2025 | Myfembree |
| Pfizer INC. | $368.69 | 2019-2024 | |
| Organon LLC | $308.86 | 2023-2025 | Nexplanon |
| Myovant Sciences INC. | $287.84 | 2021-2022 | |
| Therapeuticsmd, INC. | $282.80 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $246.46 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $244.33 | 2019-2025 | |
| Agile Therapeutics, INC. | $159.04 | 2022-2024 | Twirla |
| Millicent US INC | $158.26 | 2024-2025 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $131.62 | 2021-2022 | |
| Exeltis, USA INC. | $110.54 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $98.44 | 2019-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $90.69 | 2019 | |
| Daiichi Sankyo INC. | $53.71 | 2020 | |
| Merck Sharp & Dohme LLC | $44.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.85 | 2024-2025 | Xifaxan, Trulance |
| Boston Scientific Corporation | $30.45 | 2023 | Watchman Access System, Rezum Generator |
| Sage Therapeutics, LLC | $28.85 | 2024 | |
| Ethicon US, LLC | $26.66 | 2023 | Enseal X1, Harmonic, Monocryl |
| Lupin INC. | $25.36 | 2019 | |
| Exact Sciences Corporation | $19.41 | 2025 | The Cologuard Plus Collection Kit |
| Minerva Surgical, INC | $14.12 | 2020 | |
| Becton, Dickinson and Company | $12.75 | 2021 | |
| Meditrina | $6.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Shipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.